Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMDZ

Immune Design (IMDZ) Stock Price, News & Analysis

Immune Design logo

About Immune Design Stock (NASDAQ:IMDZ)

Key Stats

Today's Range
$5.85
$5.85
50-Day Range
$5.85
$5.85
52-Week Range
$1.10
$5.85
Volume
N/A
Average Volume
374,216 shs
Market Capitalization
$282.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMDZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Design and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMDZ Stock News Headlines

Refund From 1933: Trump’s Reset May Create Instant Wealth
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real wealth for early adopters In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate. Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel
See More Headlines

IMDZ Stock Analysis - Frequently Asked Questions

Immune Design Corp. (NASDAQ:IMDZ) released its quarterly earnings data on Wednesday, August, 1st. The biotechnology company reported ($0.29) earnings per share for the quarter, beating analysts' consensus estimates of ($0.30) by $0.01. The biotechnology company earned $0.76 million during the quarter, compared to analyst estimates of $0.64 million. Immune Design had a negative trailing twelve-month return on equity of 49.56% and a negative net margin of 2,483.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immune Design investors own include Omeros (OMER), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL), SCYNEXIS (SCYX), Selecta Biosciences (SELB), TG Therapeutics (TGTX) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
8/01/2018
Today
9/23/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:IMDZ
CIK
1437786
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.76 million
Net Margins
-2,483.00%
Pretax Margin
N/A
Return on Equity
-49.56%
Return on Assets
-46.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.33
Quick Ratio
11.32

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
128.62
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.91 per share
Price / Book
3.06

Miscellaneous

Outstanding Shares
48,370,000
Free Float
N/A
Market Cap
$282.96 million
Optionable
Optionable
Beta
3.48
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:IMDZ) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners